PDD0010 - Clinical Pharmacology

Course Description

Clinical and basic pharmacology share much common ground yet, there are also some particular differences—one of the differences in the culture between clinical and basic pharmacologists. Basic pharmacologists choose their experimental preparations with care and minimize potential sources of variation. Factors like species, age, sex, and so on can be extensively standardized. However, clinical pharmacologists deal with huge numbers of human subjects to translate reliable conclusions. The endpoint of interest is a clinical outcome. Some examples of these outcomes include stroke, death, or myocardial infarction, with tens of thousands of subjects enrolled in clinical trials.Furthermore, there are many fields in which clinical pharmacologists are engaged. Some of these fields include health policy, pharmacovigilance, safety pharmacology, and human clinical trials, including pivotal Phase III efficacy studies. The topics mentioned above are some of the strengths of clinical pharmacology. Despite the fundamental similarities between basic and clinical pharmacology, it is necessary to facilitate engagement that melds the two different perspectives. Therefore, we created this course to highlight some of the key areas of clinical pharmacologist for basic scientists. This course is taught by Vanderbilt’s Clinical Pharmacology Fellows and is meant to serve as a surface a few key areas of clinical pharmacology. Learning objective: (1)Identify the intersection of basic pharmacology and practical applications to clinical pharmacology, (2) Utilize databases and medication references at Vanderbilt that aid in the practice of clinical pharmacology, (3)Defend the clinical action plan for a clinical case report